Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Cytek Biosciences (CTKB) Cost of Revenue (2020 - 2026)

Cytek Biosciences filings provide 6 years of Cost of Revenue readings, the most recent being $29.3 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 146.39% to $29.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $65.6 million, a 4.26% decrease, with the full-year FY2025 number at $97.0 million, up 97.57% from a year prior.
  • Cost of Revenue hit $29.3 million in Q4 2025 for Cytek Biosciences, up from $11.7 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $29.3 million in Q4 2025 to a low of -$9.3 million in Q4 2023.
  • Median Cost of Revenue over the past 5 years was $12.8 million (2021), compared with a mean of $13.5 million.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 248.58% in 2021 and later plummeted 148.81% in 2023.
  • Cytek Biosciences' Cost of Revenue stood at $15.3 million in 2021, then grew by 24.28% to $19.0 million in 2022, then plummeted by 148.81% to -$9.3 million in 2023, then soared by 228.28% to $11.9 million in 2024, then soared by 146.39% to $29.3 million in 2025.
  • The last three reported values for Cost of Revenue were $29.3 million (Q4 2025), $11.7 million (Q3 2025), and $12.1 million (Q2 2025) per Business Quant data.